HEATHER WARD: Open Payments
NPI 1871537480 · COLUMBIA CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 50 payments from 16 companies in 2025. Trend: 2023 $224 · 2024 $991 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $168 |
| Abbott Laboratories | 4 | $94 |
| Lilly USA, LLC | 4 | $86 |
| Novo Nordisk Inc | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Exact Sciences Corporation | 3 | $47 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| ABIOMED | 1 | $41 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, UBRELVY, REXULTI, VRAYLAR, Cologuard Collection Kit, Wegovy, Auvelity.
Industry payments across IN — which companies pay providers there.
